CountryPoland
Medical Devices
Product Registration

Market Access for Product-Registration in Poland

Navigating the intricate landscape of global product registration requires a robust market access strategy. Taevas Life Sciences provides comprehensive solutions to ensure your innovative products achieve optimal market entry and sustained commercial succ

Start Market Access
Market
Global
Industry
Product-Registration
Regulator
International Regulatory Bodies & Local Health Authorities
Timeline
8-12 weeks (initial strategy)
Deliverables
Strategic Market Access Plan, Pricing & Reimbursement Dossier Guidance, Stakeholder Engagement Roadmap
What We Deliver

6 Pillars of Market Access

Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.

01

Global Regulatory Intelligence & Landscape Analysis

We provide in-depth analysis of the complex and evolving regulatory requirements across target global markets, identifying critical pathways and potential hurdles for product registration.

Comprehensive regulatory pathway mapping
Risk assessment and mitigation strategies
How It Works

How It Works

A structured engagement — typically delivered in a few weeks.

Step 1 · Week 1-2

Discovery & Scope Definition

We begin with a comprehensive assessment of your product, therapeutic area, and target markets to define the project scope and key objectives. This ensures a tailored approach to your unique needs.

Market Snapshot

Market Overview: Global + Product-Registration

Increasing Regulatory Divergence

Global markets are experiencing growing divergence in regulatory requirements, HTA methodologies, and pricing policies, demanding highly specialized strategies for successful product registration and market entry.

Value-Based Access Imperative

Payers globally are increasingly demanding evidence of real-world value and cost-effectiveness. Products must demonstrate clear clinical and economic benefits to secure favorable reimbursement and broad patient access.

Digital Transformation in Access

The adoption of digital health technologies and real-world data is reshaping market access strategies, offering new avenues for evidence generation, patient engagement, and accelerated pathways.

What's Included

Deliverables

A structured, decision-ready package of deliverables.

Comprehensive Market Access Strategy Report

A detailed report outlining regulatory pathways, HTA considerations, pricing recommendations, and stakeholder engagement plans for your target markets.

Reimbursement Dossier Preparation Guidelines

Expert guidance and templates to compile robust reimbursement dossiers that meet the specific requirements of key global payers and HTA bodies.

Global Stakeholder Engagement & Communication Plan

A strategic plan for identifying and engaging with critical stakeholders, including patient advocacy groups, medical societies, and policymakers, to build support for your product.

Who This Is For

Use Cases

New Market Entry

Launching a Novel Therapeutic in Emerging Markets

A biotech company with a breakthrough oncology drug needed to navigate diverse regulatory and reimbursement landscapes across Asia and Latin America for its first global launch.

Outcome
Taevas developed a phased market access strategy, securing registration and favorable reimbursement in multiple key markets within 18 months.
FAQ

Frequently Asked Questions

Get Started

Ready to Start Market Access in Global?

Partner with Taevas Life Sciences to transform your global product registration challenges into market access triumphs. Let our expertise pave the way for your commercial success.

Navigate Global Complexities
Maximize Commercial Potential
Accelerate Patient Access
Mitigate Regulatory Risks